Insurance denied genetic testing? How to appeal
The short answer
Plans usually deny genetic tests as not medically necessary or experimental, often because the records do not show how the result will change your treatment. Get the plan’s written testing policy, then have your doctor or genetic counselor show, criterion by criterion, why you qualify and what decision the result will drive. If the plan says no again, most denials of this kind can go to an independent external review.
- StartThe denial letterFind what was denied, the reason, and the deadline to appeal.
- Step 1Appeal to your planMost plans give you 60 to 180 days to ask. The plan reviews its own decision.
- Step 2Go outside the planIf it says no again, someone outside the plan can decide: an independent reviewer, a hearing, or a federal office.
Can’t wait? If waiting could seriously harm your health, ask for a fast appeal. Most plans must decide within 72 hours.
Why plans deny genetic tests
Most denials fall into a few groups:
- Not medically necessary. The plan says the result would not change your care. One large insurer’s public policy covers some tests only when “the result of the test will directly impact the treatment being delivered to the member.”
- Experimental or investigational. Common for newer panels and whole exome or genome sequencing. An employer plan’s finding that a test is experimental is a denial you can appeal.
- Missing steps. Some policies require counseling first. The same insurer’s policy for exome or genome sequencing requires that the member “receives pre- and post-test counseling” from an appropriate provider.
- No prior authorization or a coding problem. Lab claims are often billed with many codes. See denials for no prior authorization and billing or coding errors.
Get the plan’s genetic testing policy
Insurers publish their genetic testing policies, often one per test type. For employer plans, the denial letter must give the specific reason and, if the plan used an internal guideline, say that a copy is free on request. You can also ask for copies of all documents and records relevant to your claim.
Medicare has its own written rules. Its national coverage decision on next-generation sequencing covers tumor testing for patients with “recurrent, relapsed, refractory, metastatic, or advanced stage III or IV cancer” when other conditions are met, including that the test is FDA-approved or cleared for that use. Medicare Advantage plans must follow Traditional Medicare’s coverage conditions, including these decisions.
What records help
Line up each item in the policy with a page in your chart. Ask the ordering doctor or genetic counselor for:
- A letter of medical necessity that names the exact test, the genes it covers and why a narrower test would not answer the question.
- Your personal and family history, written out as a pedigree when the policy asks for one, with ages at diagnosis.
- Notes from genetic counseling, if the policy requires it.
- The specific decision the result will drive: surgery, a drug choice, a screening schedule, or stopping a diagnostic search that has already cost months.
- Prior test results, so the plan can see this is not a repeat.
Ask for the right reviewer
On appeal, an employer plan must consult a health care professional with training and experience in the field involved. For a genetic test, you can ask in your appeal letter that a clinical geneticist or the relevant specialist review the case. If the plan relied on outside experts, you can ask for their names.
When waiting could harm you, ask for a fast decision
If waiting for a standard decision could seriously harm your health, for example when a result will decide cancer treatment, ask for an expedited appeal and have the treating clinician say so in writing. Employer plans must decide urgent appeals within 72 hours, and a treating doctor’s judgment that the claim is urgent counts. A Medicare Advantage plan must expedite an appeal when a physician supports the request and decide it within 72 hours.
In urgent cases you can also ask for an external review at the same time as your internal appeal. See how to ask for an expedited appeal.
If the plan says no again
Most plans give you one or two internal appeal levels. After that, you can usually ask for an independent external review. It covers denials based on medical necessity, level of care, or a finding that a treatment is experimental. On HealthCare.gov’s description, you must file within 4 months of the final denial.
In Medicare Advantage, if the plan upholds its denial, it must send your case file to an independent reviewer contracted by CMS. You do not have to file that step yourself.
See external review, employer plans, Marketplace plans, Medicare Advantage and Medicaid.
Questions people ask
Why did my insurance deny genetic testing?
The most common reasons are that the plan finds the test not medically necessary, calls it experimental, or says required steps such as counseling or prior authorization were missing. The denial letter must state the specific reason.
Does Medicare cover genetic testing for cancer?
In some cases. Medicare’s national coverage decision on next-generation sequencing covers certain tumor tests for advanced, recurrent or metastatic cancer when conditions are met, and some inherited-risk testing for people with breast or ovarian cancer.
Can I appeal a denial for whole exome sequencing?
Yes. A finding that a test is experimental is an appealable denial, and it can usually go to external review if the plan says no again.
Who should write the appeal for a genetic test?
Usually the ordering doctor or genetic counselor, with your signature. Labs sometimes appeal on your behalf too. Ask who is filing so two appeals do not cross.
Sources
- Aetna: Genetic Testing (Clinical Policy Bulletin 0140)
The result of the test will directly impact the treatment being delivered to the member
- eCFR (National Archives): 29 CFR 2560.503-1(m)(4) (Claims procedure)
a failure to cover an item or service for which benefits are otherwise provided because it is determined to be experimental or investigational or not medically necessary or appropriate
- CMS Medicare Coverage Database: NCD 90.2 Next Generation Sequencing (NGS)
either recurrent, relapsed, refractory, metastatic, or advanced stage III or IV cancer
- eCFR (National Archives): 42 CFR 422.101(b) (Requirements relating to basic benefits)
General coverage and benefit conditions included in Traditional Medicare laws, unless superseded by laws applicable to MA plans.
- eCFR (National Archives): 42 CFR 422.584(c)(2)(ii) (Expediting certain reconsiderations)
For a request made or supported by a physician, the MA organization must provide an expedited reconsideration
- eCFR (National Archives): 42 CFR 422.590(e)(1) (Timeframes for reconsiderations)
notice of its decision as expeditiously as the enrollee's health condition requires but no later than 72 hours
- HealthCare.gov: Internal appeals
If you have an urgent health situation, you can ask for an external review at the same time as your internal appeal.
- eCFR (National Archives): 45 CFR 147.136(d)(1)(i)(A) (External review scope)
requirements for medical necessity, appropriateness, health care setting, level of care, or effectiveness of a covered benefit; its determination that a treatment is experimental or investigational
- HealthCare.gov: External Review
You must file a written request for an external review within 4 months after the date you receive a notice or final determination from your insurer that your claim has been denied.
This page is general information about appeal rules in the United States. It is not legal or medical advice. Rules can change, and your plan’s documents and your denial letter control the dates that apply to you.